D. Western Therapeutics Institute, Inc. (TYO:4576)

Japan · Delayed Price · Currency is JPY

88.00

0.00 (0.00%)

Aug 27, 2026, 3:30 PM JST

TYO:4576 Financials Overview

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	247	387	471	428	448	414
Revenue Growth	-41.33%	-17.83%	10.05%	-4.46%	8.21%	16.62%
Gross Profit	226	348	424	392	420	393
Operating Income	-625	-620	-1,210	-798	-306	-172
Net Income	-639	-632	-1,290	-812	-429	-148
Earnings Per Share	-11.97	-13.19	-36.73	-25.55	-14.47	-5.05
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Japan	60.08	136.1	150.64	227.44	174.59
Netherlands	327.22	335.48	277.7	220.66	170.1
Others	0.32	0.01	0.03	-	-
Total	387.62	471.58	428.36	448.1	414.42

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,581	1,709	1,126	1,867	2,334	1,933
Total Debt	583	605	797	884	967	339
Net Cash (Debt)	998	1,104	329	983	1,367	1,594
Net Cash Growth	88.30%	235.56%	-66.53%	-28.09%	-14.24%	-13.74%
Net Cash Per Share	18.69	23.03	9.37	30.93	46.12	54.34

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-625	-493	-1,299	-586	-354	-176
Capital Expenditures	-6	-2	-9	-12	-9	-2
Free Cash Flow	-631	-495	-1,308	-598	-363	-178
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	91.50%	89.92%	90.02%	91.59%	93.75%	94.93%
Operating Margin	-253.04%	-160.21%	-256.90%	-186.45%	-68.30%	-41.55%
Pretax Margin	-258.30%	-163.05%	-273.67%	-192.99%	-98.21%	-38.41%
Profit Margin	-258.70%	-163.31%	-273.88%	-189.72%	-95.76%	-35.75%
FCF Margin	-255.47%	-127.91%	-277.71%	-139.72%	-81.03%	-42.99%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	20.50	13.46	17.47	10.58	17.85	15.32